-
公开(公告)号:CA2408369A1
公开(公告)日:2002-11-07
申请号:CA2408369
申请日:2001-05-09
Applicant: BASF AG
Inventor: KOCK MICHAEL , GRANDEL ROLAND , LUBISCH WILFRIED , HOLZENKAMP UTA , HOGER THOMAS , SCHULT SABINE , MULLER REINHOLD
IPC: A61K31/404 , A61K31/496 , A61P3/10 , A61P7/00 , A61P9/08 , A61P9/10 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P35/00 , A61P37/02 , A61P43/00 , C07D209/08 , C07D209/12 , C07D209/10 , C07D209/14 , C07D401/04 , C07D403/04 , C07D409/04
Abstract: The invention relates to novel indole derivatives, to the production thereof and to the use thereof as inhibitors of the enzyme poly(ADP ribose)polymeras e or PARP (EC 2.4.2.30) for producing medicaments.
-
22.
公开(公告)号:SK282680B6
公开(公告)日:2002-11-06
申请号:SK74599
申请日:1997-11-28
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS-JORG
IPC: C07D295/12 , A61K31/16 , A61K31/166 , A61K31/381 , A61K31/40 , A61K31/4164 , A61K31/4402 , A61K31/4409 , A61K31/4439 , A61K31/4453 , A61K31/4468 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61P9/10 , A61P25/00 , A61P25/08 , A61P25/28 , A61P35/00 , A61P43/00 , C07C233/87 , C07C237/22 , C07C237/36 , C07C237/42 , C07C311/19 , C07C311/21 , C07D211/58 , C07D213/56 , C07D215/12 , C07D215/36 , C07D215/48 , C07D233/54 , C07D233/61 , C07D241/42 , C07D241/44 , C07D295/02 , C07D295/13 , C07D333/38 , C07D333/56 , C07D333/60 , C07D401/12 , C07D521/00 , C07K5/02
Abstract: Disclosed are compounds of general formula (I) and their tautomeric and isomeric forms, optionally their physiologically acceptable salts, where the meaning of the substituents is stated in the description. Disclosed is their use for preparation of medicaments to treat the diseases, in which the increased activities of calpain occur. For example ischemic disease of heart, kidneys or central nervous system, inflammations, muscular dystrophy, cataract, etc.
-
公开(公告)号:PT1025100E
公开(公告)日:2002-07-31
申请号:PT98951491
申请日:1998-10-05
Applicant: BASF AG
Inventor: STEINER GERD , TESCHENDORF HANS-JUERGEN , EMLING FRANZ , WICKE KARSTEN , LUBISCH WILFRIED , DULLWEBER UTA , STARCK DOROTHEA , BACH ALFRED , GARCIA-LADONA XAVIER
IPC: A61K31/519 , A61P1/00 , A61P1/14 , A61P3/04 , A61P5/00 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D471/00 , C07D471/04
Abstract: 3-substituted tetrahydropyridopyrimidinone derivatives of the formula (I) wherein the radicals have the meanings given in the Description, to a method for producing said derivatives and, to their use for producing active ingredients for drugs.
-
24.
公开(公告)号:BG63602B1
公开(公告)日:2002-06-28
申请号:BG10312299
申请日:1999-01-27
Applicant: BASF AG
Inventor: STEINER GERD , LUBISCH WILFRIED , BACH ALFRED , EMLING FRANZ , WICKE KARSTEN , TESCHENDORF HANS-JUERGEN , BEHL BERTHOLD , KERRIGAN FRANK , CHEETHAM SHARON
IPC: A61K31/435 , A61K31/519 , A61P25/24 , A61P43/00 , C07D211/00 , C07D239/00 , C07D333/00 , C07D495/14
Abstract: The 3-substituted 3,4,5,6,7.8-hexahydro-pyrido[4', 3': 4,5]-thieno [2,3-d] pyrimidine derivatives can be used as medicamentous forms for diseases where there is redud serotonin concentration and where, within the therapy, the activity of the presnaptic receptors 5-HT1B-, 5-HT1A-, 5-HT1D-, should be blocked without seriously affecting any other receptors. Depression is an example for such morbid state. The compounds have formula in which R1 is hydrogen, C1-C4-alkyl group, acetyl, benzoyl, phenylalkyl-C1-C4-residue where the aromatic residue is optionally substituted with halogen, C1-C4-alkyl, trifluoromethyl, hydroxy-, C1-C4-alkoxy-, amino-, cyano- or nitrogroups or is naphtalene-C1-C4-alkyl residue, phenylalkanon-C2-C4-residue or phenylcarbamoylalkyl-C2-residue where the phenyl group can be substituted by halogen; R2 optionally is mono-, di- or trisubstituted with halogen atoms, C1-C4-alkyl, trifluoromethyl, trifluormethoxy, hydroxy, C1-C4-alkoxy, amino-, monomethylamino-, diethylamino-, cyano- or nitrogroup, phenyl, pyridyl, pyrimidinyl or pyrasinyl reside which can optionally be ringed by one benzene ring which optionally can be mono- or disubstituted with halogen atom, C1-C4-alkyl, hydroxy, trifluormethyl, C1-C4-alkoxy, amino-, cyano- or nitrogroup, and optionally can contain one nitrogen atom or be ringed by 5- or 6-member ring which can contain one to two oxygen atoms, or can be substituted by phenyl-C1-C2-alkyl, or alkoxygroup, respectively, where the phenyl residue can be substituted with halogen, methyl, trifluormethyl or methoxygroup. A is NH or oxygen, B is hydrogen or methyl, C is hydrogen, methyl or hydroxy, X is nitrogen atom, Y is the group CH2, CH2- CH2, CH2-CH2-CH2 or CH2-CH, Z is nitrogen atom, carbon or CH where the bond between Y and Z can be double, n has the value of 2, 3 or 4. The invention also relates to physiologically acceptable salts of the above compounds. 6 claims
-
公开(公告)号:AU748613B2
公开(公告)日:2002-06-06
申请号:AU1149799
申请日:1998-10-05
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , DULLWEBER UTA , STARCK DOROTHEA , STEINER GERD , BACH ALFRED , EMLING FRANZ , GARCIA-LADONA XAVIER , TESCHENDORF HANS-JURGEN , WICKE KARSTEN
IPC: A61K31/428 , A61P25/24 , A61P43/00 , C07D275/06 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , A61K31/425
Abstract: where the substituents have the meanings indicated in the description, their preparation and use as serotonin antagonists.
-
公开(公告)号:SK15962001A3
公开(公告)日:2002-06-04
申请号:SK15962001
申请日:2000-04-27
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , GRANDEL ROLAND , HOLZENKAMP UTA , SCHULT SABINE , MULLER REINHOLD
IPC: A61K31/415 , A61K31/4184 , A61K31/422 , A61K31/427 , A61K31/437 , A61K31/4439 , A61K31/4709 , A61K31/496 , A61K31/497 , A61P3/10 , A61P9/00 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/10 , A61P25/16 , C07D235/20 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D235/18 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/04 , C07D409/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04
Abstract: The present invention relates to novel benzimidazoles, their preparation and their use as inhibitors of the enzyme poly(ADP-ribose) polymerase or PARP (EC 2.4.2.30) for producing drugs.
-
27.
公开(公告)号:CZ20012373A3
公开(公告)日:2002-05-15
申请号:CZ20012373
申请日:2000-09-15
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , SCHULT SABINE , GRANDEL ROLAND , MULLER REINHOLD
IPC: A61K31/55 , A61P3/10 , A61P9/10 , A61P11/00 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/10 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P35/00 , C07D487/06
Abstract: The invention relates to compounds of formula (I) as well as to the tautomeric forms thereof, possible enantiomeric and diastereomeric forms and the prodrugs thereof, the production and use thereof, whereby the values have the meaning as given in the description.
-
公开(公告)号:DK1025100T3
公开(公告)日:2002-05-06
申请号:DK98951491
申请日:1998-10-05
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , DULLWEBER UTA , STARCK DOROTHEA , STEINER GERD , BACH ALFRED , EMLING FRANZ , GARCIA-LADONA XAVIER , TESCHENDORF HANS-JUERGEN , WICKE KARSTEN
IPC: A61K31/519 , A61P1/00 , A61P1/14 , A61P3/04 , A61P5/00 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D471/00 , C07D471/04
Abstract: 3-substituted tetrahydropyridopyrimidinone derivatives of the formula (I) wherein the radicals have the meanings given in the Description, to a method for producing said derivatives and, to their use for producing active ingredients for drugs.
-
公开(公告)号:TR200103221T2
公开(公告)日:2002-04-22
申请号:TR200103221
申请日:2000-04-27
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOEGER THOMAS , GRANDEL ROLAND , HOLZENKAMP UTA , SCHULT SABINE , MUELLER REINHOLD
IPC: A61K31/415 , A61K31/4184 , A61K31/422 , A61K31/427 , A61K31/437 , A61K31/4439 , C07D235/20 , A61K31/4709 , A61K31/496 , A61K31/497 , A61P3/10 , A61P9/00 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D235/18 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/04 , C07D409/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04
Abstract: The present invention relates to novel benzimidazoles, their preparation and their use as inhibitors of the enzyme poly(ADP-ribose) polymerase or PARP (EC 2.4.2.30) for producing drugs.
-
公开(公告)号:PL347884A1
公开(公告)日:2002-04-22
申请号:PL34788499
申请日:1999-11-23
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOEGER THOMAS , SCHULT SABINE , GRANDEL ROLAND , MUELLER REINHOLD
IPC: A61K20060101 , A61K31/4184 , A61K31/454 , A61K31/496 , A61P20060101 , A61P3/12 , A61P9/00 , A61P9/10 , A61P13/12 , A61P17/02 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D20060101 , C07D235/30 , C07D401/04 , C07D401/14 , C07D403/04
Abstract: Compounds of the formula Ia or IB where A is a saturated or monounsaturated heterocyclic, 4 - to 8-membered ring which contains one or two nitrogen atoms, and their tautomeric forms, possible enantiomeric and diastereomeric forms, their prodrugs and possible physiologically tolerated salts are useful as inhibitors of the enzyme poly(ADP-ribose)polymerase.
-
-
-
-
-
-
-
-
-